DK0659767T4 - Fremgangsmåde til fremstilling af et koncentrat af anti-D-immunoglobulin G og et farmaceutisk præparat, som indeholder dette - Google Patents

Fremgangsmåde til fremstilling af et koncentrat af anti-D-immunoglobulin G og et farmaceutisk præparat, som indeholder dette

Info

Publication number
DK0659767T4
DK0659767T4 DK93810912T DK93810912T DK0659767T4 DK 0659767 T4 DK0659767 T4 DK 0659767T4 DK 93810912 T DK93810912 T DK 93810912T DK 93810912 T DK93810912 T DK 93810912T DK 0659767 T4 DK0659767 T4 DK 0659767T4
Authority
DK
Denmark
Prior art keywords
igg
adsorbent
plasma
immunoglobulin
concentrate
Prior art date
Application number
DK93810912T
Other languages
English (en)
Other versions
DK0659767T3 (da
Inventor
Martin Dr Stucki
Peter Dr Lerch
Gerhard Hodler
Original Assignee
Zlb Bioplasma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8215103&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0659767(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zlb Bioplasma Ag filed Critical Zlb Bioplasma Ag
Application granted granted Critical
Publication of DK0659767T3 publication Critical patent/DK0659767T3/da
Publication of DK0659767T4 publication Critical patent/DK0659767T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DK93810912T 1993-12-27 1993-12-27 Fremgangsmåde til fremstilling af et koncentrat af anti-D-immunoglobulin G og et farmaceutisk præparat, som indeholder dette DK0659767T4 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93810912A EP0659767B2 (de) 1993-12-27 1993-12-27 Verfahren zur Herstellung eines Konzentrates von Anti-D-Immunoglobulin G und pharmazeutische Zusammensetzung, die dieses enthält

Publications (2)

Publication Number Publication Date
DK0659767T3 DK0659767T3 (da) 1999-09-13
DK0659767T4 true DK0659767T4 (da) 2003-02-10

Family

ID=8215103

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93810912T DK0659767T4 (da) 1993-12-27 1993-12-27 Fremgangsmåde til fremstilling af et koncentrat af anti-D-immunoglobulin G og et farmaceutisk præparat, som indeholder dette

Country Status (20)

Country Link
US (1) US5593675A (da)
EP (1) EP0659767B2 (da)
JP (1) JP2926463B2 (da)
KR (1) KR100368563B1 (da)
AT (1) ATE175979T1 (da)
AU (1) AU682243B2 (da)
CA (1) CA2138921C (da)
CZ (1) CZ286271B6 (da)
DE (1) DE59309332D1 (da)
DK (1) DK0659767T4 (da)
ES (1) ES2129076T5 (da)
FI (1) FI112168B (da)
GR (1) GR3029817T3 (da)
HU (1) HU216864B (da)
NO (1) NO315331B1 (da)
NZ (1) NZ278057A (da)
PL (1) PL180358B1 (da)
SI (1) SI9420008B (da)
TW (1) TW311884B (da)
WO (1) WO1995018155A1 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69907439T3 (de) * 1998-05-06 2014-01-02 Genentech, Inc. Reinigung von proteinen durch ionenaustauschchromatographie
US6281336B1 (en) * 1998-06-09 2001-08-28 Statens Serum Institut Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
DE19923027C2 (de) * 1999-05-19 2002-09-19 Aventis Behring Gmbh Verfahren zur Inaktivierung von Viren
US6475749B1 (en) 1999-08-11 2002-11-05 The Regents Of The University Of California Rh hybrid antibody
SE0001128D0 (sv) * 2000-03-30 2000-03-30 Amersham Pharm Biotech Ab A method of producing IgG
ES2184594B1 (es) * 2001-01-17 2004-01-01 Probitas Pharma Sa Procedimiento para la produccion de gammaglobulina g humana inactivada de virus.
EP1532983A1 (en) * 2003-11-18 2005-05-25 ZLB Bioplasma AG Immunoglobulin preparations having increased stability
CA2458750C (en) 2004-02-23 2012-02-07 Bayer Inc. Isoolefin-diolefin production process and apparatus therefor
CA2607281C (en) * 2005-05-05 2023-10-03 Duke University Anti-cd19 antibody therapy for autoimmune disease
TWI320788B (en) 2005-05-25 2010-02-21 Hoffmann La Roche Method for the purification of antibodies
AU2007291282B2 (en) * 2006-08-28 2011-10-20 Ares Trading S.A. Process for the purification of Fc-fusion proteins
WO2008025748A1 (en) * 2006-08-28 2008-03-06 Ares Trading S.A. Process for the purification of fc-containing proteins
IT1397061B1 (it) * 2009-12-28 2012-12-28 Kedrion Spa Nuovo processo di purificazione su scala industriale di gammaglobuline da plasma umano per uso industriale.
ES2716088T3 (es) 2010-02-04 2019-06-10 Csl Behring Ag Preparado de inmunoglobulina
EP2361636A1 (en) 2010-02-26 2011-08-31 CSL Behring AG Immunoglobulin preparation and storage system for an immunoglobulin preparation
RU2467783C2 (ru) * 2010-07-30 2012-11-27 Закрытое акционерное общество "БиоХимМак СТ" Способ хроматографического выделения иммуноглобулина
MX351706B (es) * 2010-09-17 2017-10-25 Baxalta Inc Estabilizacion de inmunoglobulinas a traves de una formulacion acuosa con histidina a ph acido debil a neutro.
JP6165143B2 (ja) * 2011-08-26 2017-07-19 バクスアルタ ゲーエムベーハー 血漿由来の免疫グロブリン組成物の血栓塞栓症の可能性を軽減する方法
AU2013203043B2 (en) * 2013-03-15 2016-10-06 Takeda Pharmaceutical Company Limited Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs
WO2015137530A1 (ko) * 2014-03-11 2015-09-17 주식회사 녹십자홀딩스 면역글로불린의 정제방법
US10414816B2 (en) * 2014-03-11 2019-09-17 Green Cross Holdings Corporation Method for purifying immunoglobulin
EP4349859A1 (en) * 2023-01-27 2024-04-10 CSL Behring AG Method to purify anti-d immunoglobulin g from plasma

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3869436A (en) * 1971-06-01 1975-03-04 Statens Bakteriologiska Lab Method for fractionating plasma proteins using peg and ion-exchangers
DE3271181D1 (en) * 1982-02-08 1986-06-19 Schweiz Serum & Impfinst Intravenously administrable human immunoglobuline and process for its preparation
US4434093A (en) * 1982-07-26 1984-02-28 Ortho Diagnostic Systems Inc. Methods for preparation of HBs Ag free gamma globulins
DE3640513A1 (de) * 1986-11-27 1988-06-09 Biotest Pharma Gmbh Verfahren zur herstellung eines virussicheren, lagerstabilen und intravenoes vertraeglichen immunglobulin-g-praeparates
US5118796A (en) * 1987-12-09 1992-06-02 Centocor, Incorporated Efficient large-scale purification of immunoglobulins and derivatives
US5138034A (en) * 1989-07-12 1992-08-11 The Green Cross Corporation Method of fractionating plasma proteins
US5177194A (en) * 1990-02-01 1993-01-05 Baxter International, Inc. Process for purifying immune serum globulins

Also Published As

Publication number Publication date
JPH07206708A (ja) 1995-08-08
CZ286271B6 (cs) 2000-03-15
ES2129076T3 (es) 1999-06-01
DE59309332D1 (de) 1999-03-04
PL180358B1 (pl) 2001-01-31
FI946103A0 (fi) 1994-12-27
EP0659767B1 (de) 1999-01-20
ATE175979T1 (de) 1999-02-15
CA2138921C (en) 2004-11-02
EP0659767B2 (de) 2002-11-06
NO315331B1 (no) 2003-08-18
SI9420008A (en) 1996-02-29
HUT73376A (en) 1996-07-29
FI112168B (fi) 2003-11-14
CZ249295A3 (en) 1996-01-17
GR3029817T3 (en) 1999-06-30
US5593675A (en) 1997-01-14
HU9502514D0 (en) 1995-11-28
AU1414395A (en) 1995-07-17
NZ278057A (en) 1997-03-24
FI946103A (fi) 1995-06-28
PL310435A1 (en) 1995-12-11
AU682243B2 (en) 1997-09-25
NO945032D0 (no) 1994-12-23
SI9420008B (sl) 1998-06-30
KR960701098A (ko) 1996-02-24
EP0659767A1 (de) 1995-06-28
NO945032L (no) 1995-06-28
DK0659767T3 (da) 1999-09-13
ES2129076T5 (es) 2003-05-16
HU216864B (hu) 1999-09-28
WO1995018155A1 (en) 1995-07-06
JP2926463B2 (ja) 1999-07-28
CA2138921A1 (en) 1995-06-28
TW311884B (da) 1997-08-01
KR100368563B1 (ko) 2003-04-03

Similar Documents

Publication Publication Date Title
DK0659767T4 (da) Fremgangsmåde til fremstilling af et koncentrat af anti-D-immunoglobulin G og et farmaceutisk præparat, som indeholder dette
MX9707909A (es) Purificacion de anticuerpos.
CA2200301A1 (en) Method for fractionation of sucrose-containing solutions
MX9603637A (es) Purificacion de anticuerpo.
ES2106742T3 (es) Procedimiento de purificacion de proteinas.
AU7067287A (en) Method and apparatus for separating proteins
DE3914869C1 (da)
PL285505A1 (en) Method of obtaining purifield albumin solutions
CA2213577A1 (en) A process for the preparation of factor ix from biological sources
DK0555135T3 (da) Fremgangsmåde til fremstilling af fibrinogen med meget høj renhed, således fremstillet fibrinogen med meget høj renhed, samt et farmaceutisk præparat med indhold deraf
CA2096888A1 (en) Process for the inactivation of viruses in preparations of proteins
ES2068392T3 (es) Procedimiento de purificacion de interferon.
GB9001593D0 (en) Thiophilic absorbents
AU5095990A (en) A method for cleansing streptokinases
AU7865391A (en) Method for the preparation and purification of a mixture of glycosphingolipids free from contamination by non-conventional viruses
FI935161A (fi) Menetelmä plasmaproteiinien TTR ja RBP eristämiseksi ja jatkopuhdistamiseksi